BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 17961794)

  • 1. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
    Maron BJ
    Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K; Beutler A
    J Fam Pract; 2009 Nov; 58(11):576-84. PubMed ID: 19891935
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.
    Maron BJ; Haas TS; Doerer JJ; Thompson PD; Hodges JS
    Am J Cardiol; 2009 Jul; 104(2):276-80. PubMed ID: 19576360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.
    Pelliccia A; Zipes DP; Maron BJ
    J Am Coll Cardiol; 2008 Dec; 52(24):1990-6. PubMed ID: 19055990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility.
    Hipp AA; Heitkamp HC; Röcker K; Dickhuth HH
    Int J Sports Med; 2004 Jan; 25(1):20-6. PubMed ID: 14750008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is prevention of sudden death in young athletes feasible?
    Thiene G; Basso C; Corrado D
    Cardiologia; 1999 Jun; 44(6):497-505. PubMed ID: 10443050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities.
    Link MS
    Br J Sports Med; 2009 Sep; 43(9):685-9. PubMed ID: 19734503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of sudden cardiac arrest in young athletes.
    Westrol MS; Kapitanyan R; Marques-Baptista A; Merlin MA
    Postgrad Med; 2010 Jul; 122(4):144-57. PubMed ID: 20675977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to screen athletes for cardiovascular diseases.
    Corrado D; Michieli P; Basso C; Schiavon M; Thiene G
    Cardiol Clin; 2007 Aug; 25(3):391-7, v-vi. PubMed ID: 17961793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death in young athletes.
    Mortazavi M
    Adv Pediatr; 2013; 60(1):201-15. PubMed ID: 24007846
    [No Abstract]   [Full Text] [Related]  

  • 17. Dramatic electrocardiographic changes in a junior athlete with unpredictable hypertrophic cardiomyopathy.
    de Gregorio C; Magliarditi A; Magaudda L
    Int J Cardiol; 2009 Nov; 137(3):e51-3. PubMed ID: 19411118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiograms in athletes: interpretation and diagnostic accuracy.
    Lawless CE; Best TM
    Med Sci Sports Exerc; 2008 May; 40(5):787-98. PubMed ID: 18408622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden cardiac death in athletes is usually caused by undiagnosed heart disease. Cardiac screening of young athletes under discussion].
    Börjesson M; Nylander E
    Lakartidningen; 2005 Feb 21-27; 102(8):560-3. PubMed ID: 15786908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death in young athletes: trying to find the needle in the haystack.
    Ng B; Maginot KR
    WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.